Abstract

In clinical diagnosis, it’s well known that the abnormal level of uric acid (UA) in human body is implicated in diverse human diseases, for instance, chronic heart failure, gouty arthritis, diabetes, and so on. As a primary method, an isotope dilution mass spectrometry (IDMS) has been used to obtain the accurate quantity of UA in blood or serum and also develop the certifi-cated reference material (CRM) so as to provide a SI-traceability to clinical laboratories. Due to the low solubility of UA in water, an ammonium hydroxide (NH 4 OH) has been considered as a promising solvent to increase the solubility of UA that enables the preparation of both UA and its isotope standard solution for next IDMS-based absolute quantification. But, because of using this NH 4 OH solvent, it gives rise to the unwanted degradation of UA. In this study, we sought to optimize condition for the stability of UA in NH 4 OH solution by varying the mole ratios of UA to NH 4 OH, followed by ID-LC-MRM analysis. In addi-tion, we also inspected minutely the effect of the storage temperatures. Additionally, we also performed the quantitative analysis of UA in the KRISS serum certificated reference material (CRM, 111-01-02A) with diverse mixing ratios of UA to NH 4 OH and then compared those values to its certification value. Based on our experiments, adjusting the mole ratio of 1/2 (UA/NH 4 OH) with the storage temperature of -20 o C is an effective way to secure both the solubility and stability of UA in NH 4 OH solution for next IDMS-based quantification of UA in serum.